SCHEMBL4695546

SCHEMBL4695546

COC(=O)C1c2c(cnn2CC(=O)O)C2CN1C(=O)N2OCc1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 4/20 0.34
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
MCHR1 Q99705 1/20 0.32
FKBP1A P62942 2/20 0.32
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4695537 1.00 KCNA5 (0.34) KCNA5KDM4ENPC1RAB9APOLB
SCHEMBL4695543 1.00 KCNA5 (0.34) KCNA5KDM4ENPC1RAB9APOLB
SCHEMBL5185334 0.94 KCNA5 (0.33) KCNA5NPC1RAB9APOLBCYP3A4
SCHEMBL22030701 0.93 KCNA5 (0.33) KCNA5NPC1RAB9APOLBCYP3A4
SCHEMBL4130799 0.92 POLB (0.35) KCNA5NPC1RAB9APOLBLMNA
SCHEMBL4130795 0.92 POLB (0.35) KCNA5NPC1RAB9APOLBLMNA
SCHEMBL4155718 0.91 SMN1; SMN2 (0.39) KDM4ENPC1RAB9APOLBCYP3A4
SCHEMBL4155713 0.91 SMN1; SMN2 (0.39) KDM4ENPC1RAB9APOLBCYP3A4
SCHEMBL22030700 0.91 KCNA5 (0.32) KCNA5NPC1RAB9APOLBCYP3A4
SCHEMBL22031083 0.90 PLA2G10 (0.37) KCNA5KDM4ENPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569935-B1 HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREOF AND USE OF SAME AS MEDICAMENTS, SUCH AS ANTI-BACTERIAL MEDICAMENTS AND BETA-LACTAMASE INHIBITORS NOVEXEL (FR) 2008-08-20 EP disclosed